发明名称 |
MONOVALENT ANTIGEN BINDING CONSTRUCTS TARGETING EGFR AND/OR HER2 AND USES THEREOF |
摘要 |
Provided herein are monovalent antigen-binding constructs targeting EGFR and/or HER2. The monovalent antigen-binding constructs can include at least one antigen-binding polypeptide comprising a heavy chain variable domain, wherein the antigen-bind polypeptide specifically binds EGFR and/or HER2; and a heterodimeric Fc domain, the Fc domain comprising at least two CH3 domains, wherein the Fc domain is coupled, with or without a linker, to the antigen-binding polypeptide. Also provided are methods of making the constructs and methods of using the constructs. |
申请公布号 |
US2016289328(A1) |
申请公布日期 |
2016.10.06 |
申请号 |
US201415036174 |
申请日期 |
2014.11.13 |
申请人 |
Zymeworks Inc. |
发明人 |
NG Gordon Yiu Kon;CHAN Peter Wing Yiu;WICKMAN Grant Raymond |
分类号 |
C07K16/28;C07K16/30;A61K47/48 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating a subject having an epidermal growth factor receptor (EGFR)-expressing tumor, comprising: contacting the tumor with an effective amount of an isolated monovalent EGFR-binding construct comprising at least one antigen-binding polypeptide comprising a heavy chain variable domain coupled, with or without a linker, to a heterodimeric Fc, wherein the antigen-binding polypeptide binds or specifically binds to EGFR, and wherein the construct binds to EGFR with a greater Bmax as compared to the corresponding isolated monospecific bivalent antigen-binding construct that binds or specifically binds EGFR. |
地址 |
Vancouver CA |